View in EDS PDF Full Text

Applicability and clinical significance of the SarQoL (Sarcopenia Quality of Life) tool in peritoneal dialysis patients: A preliminary report.

Saved in:
Bibliographic Details
Title: Applicability and clinical significance of the SarQoL (Sarcopenia Quality of Life) tool in peritoneal dialysis patients: A preliminary report.
Alternate Title: Aplicabilidad y relevancia clínica de la herramienta SarQoL (Sarcopenia Quality of Life) en pacientes en diálisis peritoneal: un informe preliminar.
Authors: Musolino, Michela1 mikymusolino@gmail.com, Ruosi, Federico1, Roumeliotis, Stefanos2, Kourtidou, Christodoula2, Alekos, Ioannis3, Andreucci, Michele1, Zicarelli, Mariateresa1, Coppolino, Giuseppe1, Liakopoulos, Vassilios2, Dounousi, Evangelia3, Bolignano, Davide4
Source: Nefrologia. May2026, Vol. 46 Issue 5, p1-5. 5p.
Subjects: SARCOPENIA, PERITONEAL dialysis, FUNCTIONAL status, QUESTIONNAIRES, QUALITY of life, MUSCULAR atrophy
Abstract (English): Introduction/Objectives: Sarcopenia, characterized by the progressive loss of muscle mass and strength, is highly prevalent in patients on peritoneal dialysis (PD), significantly affecting their quality of life (QoL). The SarQoL questionnaire, a newly validated tool for assessing the impact of sarcopenia on QoL, has never been evaluated in PD patients. This study aimed to explore its applicability and relevance in this population. Methods: Thirty-two adult PD patients were recruited. Sarcopenia risk was assessed using the SARC-F questionnaire, anthropometric measures (e.g., skinfold thickness, body composition), and functional tests (handgrip strength, 30 s chair-stand test). Correlations with the SarQoL score were thus explored. Results: The mean SarQoL score was 70.95 ± 15.96, indicating a low to mildly impaired QoL related to sarcopenia. Patients on automated PD (APD) scored significantly higher than those on continuous ambulatory PD (CAPD; p < 0.0001). Strong inverse relationships were observed between SarQoL and SARC-F scores (r = −0.77, p < 0.0001) and age (r = −0.50, p = 0.003). Additionally, the SarQoL score was correlated with diastolic blood pressure (r = 0.50, p = 0.003), serum albumin (r = 0.47, p = 0.006), diuresis (r = 0.46, p = 0.007), number of stands at the chair test (r = 0.46, p = 0.02), and body fat percentage (r = −0.34, p = 0.05). Conclusion: The SarQoL questionnaire may be useful for evaluating sarcopenia’s impact on well-being in PD patients. Future studies are needed to confirm these findings in wider cohorts and to explore longitudinal changes in SarQoL scores in response to interventions. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Introducción/Objetivos La sarcopenia, caracterizada por la pérdida progresiva de masa y fuerza muscular, es altamente prevalente en los pacientes en diálisis peritoneal (DP) y afecta significativamente su calidad de vida (CV). El cuestionario SarQoL, una herramienta recientemente validada para evaluar el impacto de la sarcopenia en la CV, nunca ha sido evaluado en pacientes en DP. Este estudio tuvo como objetivo explorar su aplicabilidad y relevancia en esta población. Métodos Se reclutaron treinta y dos pacientes adultos en DP. El riesgo de sarcopenia se evaluó mediante el cuestionario SARC-F, medidas antropométricas (p. ej., pliegues cutáneos, composición corporal) y pruebas funcionales (fuerza de prensión manual, test de levantarse de la silla en 30 segundos). Se analizaron las correlaciones con la puntuación del SarQoL. Resultados La puntuación media del SarQoL fue de 70,95 ± 15,96, lo que indica una CV relacionada con la sarcopenia de baja a levemente deteriorada. Los pacientes en DP automatizada (DPA) obtuvieron puntuaciones significativamente más altas que aquellos en DP continua ambulatoria (DPCA; p < 0,0001). Se observaron fuertes relaciones inversas entre la puntuación SarQoL y el SARC-F (r = −0,77; p < 0,0001) y la edad (r = −0,50; p = 0,003). Además, la puntuación SarQoL se correlacionó con la presión arterial diastólica (r = 0,50; p = 0,003), la albúmina sérica (r = 0,47; p = 0,006), la diuresis (r = 0,46; p = 0,007), el número de repeticiones en el test de la silla (r = 0,46; p = 0,02) y el porcentaje de grasa corporal (r = −0,34; p = 0,05). Conclusión El cuestionario SarQoL puede ser útil para evaluar el impacto de la sarcopenia en el bienestar de los pacientes en DP. Se necesitan estudios futuros para confirmar estos hallazgos en cohortes más amplias y explorar los cambios longitudinales en la puntuación SarQoL en respuesta a intervenciones. [ABSTRACT FROM AUTHOR]
Copyright of Nefrologia is the property of Revista Nefrologia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 193506736
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Applicability and clinical significance of the SarQoL (Sarcopenia Quality of Life) tool in peritoneal dialysis patients: A preliminary report.
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: Aplicabilidad y relevancia cl&#237;nica de la herramienta SarQoL (Sarcopenia Quality of Life) en pacientes en di&#225;lisis peritoneal: un informe preliminar.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Musolino%2C+Michela%22&quot;&gt;Musolino, Michela&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; mikymusolino@gmail.com&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ruosi%2C+Federico%22&quot;&gt;Ruosi, Federico&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Roumeliotis%2C+Stefanos%22&quot;&gt;Roumeliotis, Stefanos&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kourtidou%2C+Christodoula%22&quot;&gt;Kourtidou, Christodoula&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Alekos%2C+Ioannis%22&quot;&gt;Alekos, Ioannis&lt;/searchLink&gt;&lt;relatesTo&gt;3&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Andreucci%2C+Michele%22&quot;&gt;Andreucci, Michele&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Zicarelli%2C+Mariateresa%22&quot;&gt;Zicarelli, Mariateresa&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Coppolino%2C+Giuseppe%22&quot;&gt;Coppolino, Giuseppe&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Liakopoulos%2C+Vassilios%22&quot;&gt;Liakopoulos, Vassilios&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Dounousi%2C+Evangelia%22&quot;&gt;Dounousi, Evangelia&lt;/searchLink&gt;&lt;relatesTo&gt;3&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Bolignano%2C+Davide%22&quot;&gt;Bolignano, Davide&lt;/searchLink&gt;&lt;relatesTo&gt;4&lt;/relatesTo&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Nefrologia%22&quot;&gt;Nefrologia&lt;/searchLink&gt;. May2026, Vol. 46 Issue 5, p1-5. 5p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22SARCOPENIA%22&quot;&gt;SARCOPENIA&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22PERITONEAL+dialysis%22&quot;&gt;PERITONEAL dialysis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22FUNCTIONAL+status%22&quot;&gt;FUNCTIONAL status&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22QUESTIONNAIRES%22&quot;&gt;QUESTIONNAIRES&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22QUALITY+of+life%22&quot;&gt;QUALITY of life&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22MUSCULAR+atrophy%22&quot;&gt;MUSCULAR atrophy&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: Introduction/Objectives: Sarcopenia, characterized by the progressive loss of muscle mass and strength, is highly prevalent in patients on peritoneal dialysis (PD), significantly affecting their quality of life (QoL). The SarQoL questionnaire, a newly validated tool for assessing the impact of sarcopenia on QoL, has never been evaluated in PD patients. This study aimed to explore its applicability and relevance in this population. Methods: Thirty-two adult PD patients were recruited. Sarcopenia risk was assessed using the SARC-F questionnaire, anthropometric measures (e.g., skinfold thickness, body composition), and functional tests (handgrip strength, 30 s chair-stand test). Correlations with the SarQoL score were thus explored. Results: The mean SarQoL score was 70.95 &#177; 15.96, indicating a low to mildly impaired QoL related to sarcopenia. Patients on automated PD (APD) scored significantly higher than those on continuous ambulatory PD (CAPD; p &lt; 0.0001). Strong inverse relationships were observed between SarQoL and SARC-F scores (r = −0.77, p &lt; 0.0001) and age (r = −0.50, p = 0.003). Additionally, the SarQoL score was correlated with diastolic blood pressure (r = 0.50, p = 0.003), serum albumin (r = 0.47, p = 0.006), diuresis (r = 0.46, p = 0.007), number of stands at the chair test (r = 0.46, p = 0.02), and body fat percentage (r = −0.34, p = 0.05). Conclusion: The SarQoL questionnaire may be useful for evaluating sarcopenia’s impact on well-being in PD patients. Future studies are needed to confirm these findings in wider cohorts and to explore longitudinal changes in SarQoL scores in response to interventions. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: Introducci&#243;n/Objetivos La sarcopenia, caracterizada por la p&#233;rdida progresiva de masa y fuerza muscular, es altamente prevalente en los pacientes en di&#225;lisis peritoneal (DP) y afecta significativamente su calidad de vida (CV). El cuestionario SarQoL, una herramienta recientemente validada para evaluar el impacto de la sarcopenia en la CV, nunca ha sido evaluado en pacientes en DP. Este estudio tuvo como objetivo explorar su aplicabilidad y relevancia en esta poblaci&#243;n. M&#233;todos Se reclutaron treinta y dos pacientes adultos en DP. El riesgo de sarcopenia se evalu&#243; mediante el cuestionario SARC-F, medidas antropom&#233;tricas (p. ej., pliegues cut&#225;neos, composici&#243;n corporal) y pruebas funcionales (fuerza de prensi&#243;n manual, test de levantarse de la silla en 30 segundos). Se analizaron las correlaciones con la puntuaci&#243;n del SarQoL. Resultados La puntuaci&#243;n media del SarQoL fue de 70,95 &#177; 15,96, lo que indica una CV relacionada con la sarcopenia de baja a levemente deteriorada. Los pacientes en DP automatizada (DPA) obtuvieron puntuaciones significativamente m&#225;s altas que aquellos en DP continua ambulatoria (DPCA; p &lt; 0,0001). Se observaron fuertes relaciones inversas entre la puntuaci&#243;n SarQoL y el SARC-F (r = −0,77; p &lt; 0,0001) y la edad (r = −0,50; p = 0,003). Adem&#225;s, la puntuaci&#243;n SarQoL se correlacion&#243; con la presi&#243;n arterial diast&#243;lica (r = 0,50; p = 0,003), la alb&#250;mina s&#233;rica (r = 0,47; p = 0,006), la diuresis (r = 0,46; p = 0,007), el n&#250;mero de repeticiones en el test de la silla (r = 0,46; p = 0,02) y el porcentaje de grasa corporal (r = −0,34; p = 0,05). Conclusi&#243;n El cuestionario SarQoL puede ser &#250;til para evaluar el impacto de la sarcopenia en el bienestar de los pacientes en DP. Se necesitan estudios futuros para confirmar estos hallazgos en cohortes m&#225;s amplias y explorar los cambios longitudinales en la puntuaci&#243;n SarQoL en respuesta a intervenciones. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Nefrologia is the property of Revista Nefrologia and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=193506736
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.nefro.2026.501513
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 1
    Subjects:
      – SubjectFull: SARCOPENIA
        Type: general
      – SubjectFull: PERITONEAL dialysis
        Type: general
      – SubjectFull: FUNCTIONAL status
        Type: general
      – SubjectFull: QUESTIONNAIRES
        Type: general
      – SubjectFull: QUALITY of life
        Type: general
      – SubjectFull: MUSCULAR atrophy
        Type: general
    Titles:
      – TitleFull: Applicability and clinical significance of the SarQoL (Sarcopenia Quality of Life) tool in peritoneal dialysis patients: A preliminary report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Musolino, Michela
      – PersonEntity:
          Name:
            NameFull: Ruosi, Federico
      – PersonEntity:
          Name:
            NameFull: Roumeliotis, Stefanos
      – PersonEntity:
          Name:
            NameFull: Kourtidou, Christodoula
      – PersonEntity:
          Name:
            NameFull: Alekos, Ioannis
      – PersonEntity:
          Name:
            NameFull: Andreucci, Michele
      – PersonEntity:
          Name:
            NameFull: Zicarelli, Mariateresa
      – PersonEntity:
          Name:
            NameFull: Coppolino, Giuseppe
      – PersonEntity:
          Name:
            NameFull: Liakopoulos, Vassilios
      – PersonEntity:
          Name:
            NameFull: Dounousi, Evangelia
      – PersonEntity:
          Name:
            NameFull: Bolignano, Davide
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 02116995
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Nefrologia
              Type: main
ResultId 1